Hims & Hers halts sale of Wegovy copycat pill following FDA crackdown on weight-loss drugs
Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days after its launch, following FDA scrutiny. Here's all we know about the probe and US health department's moves.
Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days after its launch, following FDA scrutiny. Here's all we know about the probe and US health department's moves.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
